CWA
Clarus Wealth Advisors’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,766
| Closed | -$253K | – | 128 |
|
|
2024
Q4 | $253K | Buy |
+1,766
| New | +$253K | 0.13% | 106 |
|
|
2024
Q3 | – | Sell |
-1,740
| Closed | -$256K | – | 137 |
|
|
2024
Q2 | $256K | Buy |
1,740
+250
| +17% | +$36.8K | 0.14% | 107 |
|
|
2024
Q1 | $206K | Sell |
1,490
-352
| -19% | -$48.6K | 0.12% | 123 |
|
|
2023
Q4 | $252K | Buy |
+1,842
| New | +$252K | 0.15% | 100 |
|
|
2019
Q3 | – | Sell |
-802
| Closed | -$68K | – | 414 |
|
|
2019
Q2 | $68K | Buy |
802
+608
| +313% | +$51.6K | 0.05% | 241 |
|
|
2019
Q1 | $17K | Hold |
194
| – | – | 0.01% | 447 |
|
|
2018
Q4 | $14K | Buy |
194
+97
| +100% | +$7K | 0.02% | 461 |
|
|
2018
Q3 | $12K | Buy |
+97
| New | +$12K | 0.01% | 516 |
|